Beijing Hotgen Biotech Co Ltd (688068) — Cash Flow Quality Index
Beijing Hotgen Biotech Co Ltd (688068) has a Cash Flow Quality Index of -1.95x as of September 2024. Operating cash flow of CN¥-5.53 Million is below net income of CN¥2.83 Million, suggesting accrual-heavy earnings not yet converted to cash. Also explore total assets of Beijing Hotgen Biotech Co Ltd for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Beijing Hotgen Biotech Co Ltd Cash Flow Quality Index (2016–2023)
Historical Cash Flow Quality Index for Beijing Hotgen Biotech Co Ltd across 8 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 688068 goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Beijing Hotgen Biotech Co Ltd (2016–2023)
Year-by-year earnings quality comparison for Beijing Hotgen Biotech Co Ltd. For live market cap and the full company financial profile, see 688068 stock market capitalisation.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | -1.69x | CN¥-25.39 Million | CN¥15.05 Million | ▼ -259.4% |
| 2022 | 1.06x | CN¥978.75 Million | CN¥925.12 Million | ▼ -11.9% |
| 2021 | 1.20x | CN¥2.64 Billion | CN¥2.20 Billion | ▼ -18.8% |
| 2020 | 1.48x | CN¥164.62 Million | CN¥111.30 Million | ▲ +157.7% |
| 2019 | 0.57x | CN¥19.37 Million | CN¥33.75 Million | ▼ -49.7% |
| 2018 | 1.14x | CN¥55.04 Million | CN¥48.19 Million | ▲ +49.7% |
| 2017 | 0.76x | CN¥22.95 Million | CN¥30.07 Million | ▼ -51.7% |
| 2016 | 1.58x | CN¥45.54 Million | CN¥28.80 Million | — |